CIK 0001850767 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Accustem Sciences Inc.
Sign in to watch- Ticker
- ACUT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 442070661000
- Business address
- 5 PENN PLAZA, 19TH FLOOR, #1954, NEW YORK, NY, 10001
- Former names
- AccuStem Sciences Ltd
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 10,000 shares at $0.79 ($7,900)
- DRS Other Draft Registration Statement
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 20,000 shares at $0.50 ($10,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 4 Open-market buy Director bought 9,447 shares at an average $1.43 ($13,491)
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- NT 10-K Other NT 10-K
- 8-K Event Executive or director change
Page 3 of 4 · 76 filings